Reference health

White and gray matter brain development in children and young adults with phenylketonuria

https://doi.org/10.1016/j.nicl.2019.101916
CiteStamped reference-health badge
49/49 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

11 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 49 checked references that resolve
resolves10.1016/j.ymgme.2009.10.005
White matter pathology in phenylketonuria☆
resolves10.1016/j.ymgme.2013.03.020
White matter integrity and executive abilities in individuals with phenylketonuria
resolves10.1037/a0013488
Response monitoring in children with phenylketonuria.
resolves10.1080/09297049.2010.525502
Executive Strategic Processing During Verbal Fluency Performance in Children with Phenylketonuria
resolves10.18637/jss.v067.i01
Fitting Linear Mixed-Effects Models Using <b>lme4</b>
resolves10.1016/j.ymgme.2012.08.007
A volumetric study of basal ganglia structures in individuals with early-treated phenylketonuria
resolves10.1207/s15326942dn3003_5
Inhibitory Control in Children With Phenylketonuria
resolves10.1016/j.ymgme.2009.10.007
Executive function in early-treated phenylketonuria: Profile and underlying mechanisms☆☆☆
resolves10.1016/j.ymgme.2016.02.004
Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria
resolves10.1080/87565640802101482
Twenty-Five Years of Research on Neurocognitive Outcomes in Early-Treated Phenylketonuria: Intelligence and Executive Function
resolves10.1016/j.neuroimage.2010.06.010
Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature
resolves10.1002/jmri.21289
MRI abnormalities in normal‐appearing brain tissue of treated adult PKU patients
resolves10.1002/(SICI)1098-2779(1999)5:2<104::AID-MRDD2>3.0.CO;2-7
Pathophysiology of phenylketonuria
resolves10.1111/j.1469-1809.2007.00389.x
The Birth Prevalence of PKU in Populations of European, South Asian and Sub‐Saharan African Ancestry Living in South East England
resolves10.1080/87565641.2018.1438439
Developmental Trajectories of Executive and Verbal Processes in Children with Phenylketonuria
resolves10.1016/j.ymgme.2014.01.012
Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria
resolves10.1016/j.ymgme.2014.11.007
Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria
resolves10.1007/8904_2016_579
Brain White Matter Integrity Mediates the Relationship Between Phenylalanine Control and Executive Abilities in Children with Phenylketonuria
resolves10.1016/j.ymgme.2013.10.001
Executive functioning in context: Relevance for treatment and monitoring of phenylketonuria
resolves10.1007/s10519-017-9863-1
Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study
resolves10.1037/a0029419
Processing speed and executive abilities in children with phenylketonuria.
resolves10.1148/radiol.2362040611
Diffusion-weighted MR Imaging in Patients with Phenylketonuria: Relationship between Serum Phenylalanine Levels and ADC Values in Cerebral White Matter
resolves10.1055/s-2008-1071561
Neuroradiological (MRI) Abnormalities in Phenylketonuric Subjects: Clinical and Biochemical Correlations
resolves10.1007/s10545-006-0399-4
The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (<sup>1</sup>H MRS) study
resolves10.1007/s00234-009-0574-z
Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria
resolves10.1016/j.neuroimage.2013.05.077
Human Connectome Project informatics: Quality control, database services, and data visualization
resolves10.1016/j.ymgme.2015.08.005
The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study
resolves10.1016/j.ymgme.2015.04.003
Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: A longitudinal study
resolves10.1542/peds.108.4.972
National Institutes of Health Consensus Development Conference Statement: Phenylketonuria: Screening and Management, October 16–18, 2000
resolves10.1016/j.neuroimage.2008.07.009
Human brain white matter atlas: Identification and assignment of common anatomical structures in superficial white matter
resolves10.2337/dc07-0351
Regional Brain Volume Differences Associated With Hyperglycemia and Severe Hypoglycemia in Youth With Type 1 Diabetes
resolves10.1212/01.wnl.0000204415.39853.4a
Global and regional volume changes in the brains of patients with phenylketonuria
resolves10.1002/jimd.12049
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria
resolves10.3758/BRM.40.3.879
Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models
resolves10.1097/00004647-200103000-00011
Variability of Blood—Brain Ratios of Phenylalanine in Typical Patients with Phenylketonuria
resolves10.1007/s11547-009-0365-y
Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion
resolves10.1002/humu.20526
ThePAH gene, phenylketonuria, and a paradigm shift
resolves10.1038/nprot.2007.45
Acquisition and voxelwise analysis of multi-subject diffusion data with Tract-Based Spatial Statistics
resolves10.1093/brain/116.4.811
Brain MRI changes in phenylketonuria: Associations with dietary status
resolves10.1186/s13023-017-0685-2
The complete European guidelines on phenylketonuria: diagnosis and treatment
resolves10.1002/mrm.21422
Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging
resolves10.1016/j.ymgme.2007.05.006
Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta-analysis
resolves10.7189/jogh.08.021102
Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence
resolves10.1016/j.ymgme.2009.09.016
Age-related decline in the microstructural integrity of white matter in children with early- and continuously-treated PKU: A DTI study of the corpus callosum☆
resolves10.1016/j.ymgme.2013.07.010
White matter integrity and executive abilities following treatment with tetrahydrobiopterin (BH4) in individuals with phenylketonuria
resolves10.1016/j.neuroimage.2014.03.072
Typical development of basal ganglia, hippocampus, amygdala and cerebellum from age 7 to 24
resolves10.1016/j.neuroimage.2013.11.010
Unique developmental trajectories of cortical thickness and surface area
resolves10.20982/tqmp.08.1.p052
An introduction to hierarchical linear modeling
The 11 references without a DOI — listed, not checked
no DOI — not checkedAre neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
no DOI — not checkedPhenylketonuria (PKU): a problem solved?
no DOI — not checked10.1016/j.nicl.2019.101916_bb0060
no DOI — not checkedPretreatment cognitive and neural differences between sapropterin dihydrochloride responders and non-responders with phenylketonuria
no DOI — not checkedA simple sequentially rejective multiple test procedure
no DOI — not checked10.1016/j.nicl.2019.101916_bb0140
no DOI — not checkedTract-based evaluation of white matter damage in individuals with early-treated phenylketonuria
no DOI — not checkedMR imaging-based volumetry in patients with early-treated phenylketonuria
no DOI — not checked10.1016/j.nicl.2019.101916_bb0215
no DOI — not checked10.1016/j.nicl.2019.101916_bb0220
no DOI — not checked10.1016/j.nicl.2019.101916_bb0270
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.nicl.2019.101916"><img src="https://citestamp.com/citestamped/10.1016/j.nicl.2019.101916/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.nicl.2019.101916/badge.svg)](https://citestamp.com/citestamped/10.1016/j.nicl.2019.101916)